July 24, 2020 by Chain Drug Review
Administration’s Executive Order to resurrect the rebate rule, Pharmaceutical Care Management Association (PCMA), Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott
Leading Headlines, Pharmacy
WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued the following statement on the Administration’s Executive Order to resurrect the rebate rule: “The Administration’s decision last year to withdraw a proposed regulation on prescription drug rebates was the right decision. Reviving a rebate reform proposal now does not address the underlying
May 26, 2020 by Chain Drug Review
Pharmaceutical Care Management Association (PCMA), Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott
Leading Headlines, Pharmacy
WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott issued on Tuesday the following statement applauding the Administration’s initiative, announced today, to reduce insulin costs for Medicare enrollees: “We commend the Administration for allowing Part D plan sponsors to offer a new, voluntary Medicare Part D plan, starting in 2021, under which
May 8, 2020 by Chain Drug Review
HB 978/SB 915, JC Scott, Pharmaceutical Care Management Association (PCMA)
Leading Headlines, Pharmacy
WASHINGTON — The Pharmaceutical Care Management Association (PCMA) issued on Friday the following statement applauding the Maryland legislature and Governor Larry Hogan for enacting first-of-its-kind legislation, HB 978/SB 915, to increase transparency in the prescription drug supply chain. The legislation, sponsored by Delegate Ariana Kelly and Senator Benjamin Kramer, will give Maryland policymakers and the
March 25, 2020 by Chain Drug Review
JC Scott, Pharmaceutical Care Management Association (PCMA), Rutledge versus PCMA
Leading Headlines, Pharmacy
WASHINGTON — On Wednesday, the Pharmaceutical Care Management Association (PCMA) filed its brief with the U.S. Supreme Court in the case of Rutledge versus PCMA, arguing that a misguided Arkansas law creates inefficiencies in employer-sponsored health plans and threatens access to prescription drugs. The brief comes in advance of anticipated oral arguments next month. Unique state
March 11, 2020 by Chain Drug Review
JC Scott, PCMA, Pharmaceutical Care Management Association (PCMA), Regina Stivers
Leading Headlines, Pharmacy
WASHINGTON — The Pharmaceutical Care Management Association (PCMA) has announced that Regina Stivers as PCMA’s newest staff addition. Stivers joins PCMA as director, state affairs. She brings a tremendous amount of experience, having worked in both federal and state government and in the private sector overseeing economic development. Before joining PCMA, Regina served as both
February 19, 2020 by Chain Drug Review
JC Scott, Pharmaceutical Care Management Association (PCMA)
Leading Headlines, Pharmacy
WASHINGTON — As prescription drug spending is poised to reach as much as $5 trillion during the next decade, new data find that pharmacy benefit managers’ (PBMs’) proven cost savings and patient care management tools should reduce prescription drug costs for health plan sponsors and consumers by an average of 20%, or more than $1
September 25, 2019 by Chain Drug Review
JC Scott, Jon Roberts CVS Health, Pharmaceutical Care Management Association (PCMA)
Leading Headlines, Pharmacy
WASHINGTON — On Wednesday, the Pharmaceutical Care Management Association (PCMA) announced that Jon Roberts, executive vice president and chief operating officer of CVS Health becomes chairman of PCMA’s board of directors. “I’m honored to serve as chairman of the PCMA board of directors, supporting the association’s efforts to change the dialogue around prescription drugs with a
September 16, 2019 by Chain Drug Review
Pharmaceutical Care Management Association (PCMA), Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott, prescription drug rebates in Medicare Part D
Leading Headlines, Pharmacy
WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott issued the following statement on the Health and Human Services Officer of Inspector General report (OIG) on prescription drug rebates in Medicare Part D. “Today’s OIG report further dispels the false narrative about PBM-negotiated rebates and confirms that rebates lead to lower prescription
July 11, 2019 by Chain Drug Review
JC Scott, PBMs, Pharmaceutical Care Management Association (PCMA)
Leading Headlines, Pharmacy
WASHINGTON — The Pharmaceutical Care Management Association (PCMA) issued the following statement on today’s action by the House Energy and Commerce Subcommittee on Health drug pricing transparency legislation: PCMA applauds the Energy and Commerce Subcommittee on Health for advancing legislation promoting real-time benefit tools to give prescribers and patients at the point of prescribing information on
July 11, 2019 by Chain Drug Review
JC Scott, PCMA, Pharmaceutical Care Management Association (PCMA)
Leading Headlines, Pharmacy
WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott issued the following statement on the Administration’s decision to withdraw the proposed rule on prescription drug rebates: “We understand that high prescription drug prices are a burden for too many Americans. There is still a problem of affordability for consumers that
July 9, 2019 by Chain Drug Review
IngenioRx, JC Scott, Pharmaceutical Care Management Association (PCMA)
Leading Headlines, Pharmacy
WASHINGTON — The Pharmaceutical Care Management Association (PCMA) is announcing the addition of IngenioRx as its newest member company. IngenioRx provides pharmacy benefit management services to payers, including affiliates of Anthem, Inc. (ANTM), and is focused on bringing new clarity to the complicated world of pharmacy so members get the benefits they need in a way that’s
March 7, 2019 by Chain Drug Review
J.C. Scott, Pharmaceutical Care Management Association (PCMA), prescription drug pricing issues
Leading Headlines, Pharmacy
(Washington, D.C.) — As several congressional committees today examine prescription drug pricing issues Pharmaceutical Care Management Association (PCMA) president and chief executive officer J.C. Scott released the following statement: “We applaud the Senate Aging Committee, the House Ways and Means Subcommittee on Health, and the House Judiciary Subcommittee on Antitrust, Commercial, and Administrative Law for holding today’s
February 25, 2019 by Chain Drug Review
J.C. Scott, Pharmaceutical Care Management Association (PCMA)
Leading Headlines, Pharmacy
WASHINGTON — The Pharmaceutical Care Management Association (PCMA) is launching a new print and digital ad campaign – “Protect the Savings” – to defend the savings that pharmacy benefit managers (PBMs) negotiate from drugmakers, and warn against the Administration’s newly proposed regulation that would eliminate these savings for beneficiaries and significantly increases costs to taxpayers. Click
February 4, 2019 by Chain Drug Review
JC Scott, OnYourRxSide, Pharmaceutical Care Management Association (PCMA), pharmacy benefit managers (PBMs)
Leading Headlines, Pharmacy
WASHINGTON— As the debate on prescription drug costs continues and policymakers seek solutions to reduce out-of-control prices for consumers, the Pharmaceutical Care Management Association (PCMA) today is announcing the launch of a new, multi-faceted digital public affairs campaign OnYourRxSide. The campaign is designed to increase awareness of the value that pharmacy benefit managers (PBMs) bring to patients and the employers and public programs